Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane (Q46696565)
scientific article
Language:
Current Data About Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane
(P31) (Q13442814)
(P248)
(P698) 18347007
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/18347007

(P50) (Q38524069)
(P1545) 5
(P248)
(P698) 18347007
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/18347007

(Q91794468)
(P1545) 12
(P1932) Kathy D Miller
(P248)
(P698) 18347007
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/18347007

(Q55975497)
(P1545) 3
(P1932) Hope S Rugo
(P248)
(P698) 18347007
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/18347007

(P304) 1810-1816
(P248)
(P698) 18347007
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/18347007

(P407) (Q1860)

(P433) 11
(P248)
(P698) 18347007
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/18347007

(P478) 26
(P248)
(P698) 18347007
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/18347007

(P577) Monday, March 17, 2008
(P248)
(P698) 18347007
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/18347007

(P921) (Q181600)

(Q12859063)
(P887)

(P1433) (Q400292)
(P248)
(P698) 18347007
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/18347007

(P1476) "Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane" (language: en)
(P248)
(P698) 18347007
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/18347007

(P2093) Harold J Burstein
(P1545) 1
(P248)
(P698) 18347007
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/18347007

Anthony D Elias
(P1545) 2
(P248)
(P698) 18347007
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/18347007

Melody A Cobleigh
(P1545) 4
(P248)
(P698) 18347007
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/18347007

Peter D Eisenberg
(P1545) 6
(P248)
(P698) 18347007
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/18347007

Mary Lehman
(P1545) 7
(P248)
(P698) 18347007
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/18347007

Bonne J Adams
(P1545) 8
(P248)
(P698) 18347007
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/18347007

Carlo L Bello
(P1545) 9
(P248)
(P698) 18347007
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/18347007

Samuel E DePrimo
(P1545) 10
(P248)
(P698) 18347007
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/18347007

Charles M Baum
(P1545) 11
(P248)
(P698) 18347007
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/18347007

other details
description scientific article

External Links
(P356) 10.1200/JCO.2007.14.5375
(P698) 18347007
(P5875) 5505484